Change in Pneumococcus Serotypes but not Mortality or Morbidity in Pre- and Post-13-Valent Polysaccharide Conjugate Vaccine Era: Epidemiology in a Pediatric Intensive Care Unit over 10 Years
Author(s) -
KamLun Ellis Hon,
King Hang Chan,
Pak Long Ko,
Michelle Ho Yan Cheung,
Kathy Yin Ching Tsang,
Lawrence Chan,
Renee W. Y. Chan,
Ting Fan Leung,
Margaret Ip
Publication year - 2017
Publication title -
journal of tropical pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.464
H-Index - 51
eISSN - 1465-3664
pISSN - 0142-6338
DOI - 10.1093/tropej/fmx084
Subject(s) - medicine , epidemiology , serotype , conjugate vaccine , intensive care unit , intensive care medicine , pneumococcal conjugate vaccine , pediatrics , environmental health , virology , microbiology and biotechnology , streptococcus pneumoniae , immunology , immunization , antibiotics , antigen , biology
Pneumococcus is a common commensal and an important pathogen among children for which immunization is available. Some serotypes occasionally cause severe pneumococcal disease with high mortality and morbidity. We reviewed all pneumococcal serotypes and mortality/morbidity in a pediatric intensive care unit (PICU) following universal pneumococcal conjugate vaccine (PCV) immunization.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom